Full Press Release Details
immatics Raises EUR 54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio.
IMTX
immatics Raises EUR 54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio
Key Takeaway: immatics Raises EUR 54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio